Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HAUS augmin like complex subunit 4 pseudogene 1 (HAUS4P1) is classified as a pseudogene, meaning it resembles a functional gene (in this case, a subunit of the augmin/HAUS complex) but is incapable of producing a functional protein product due to disabling mutations[4][3]. Pseudogenes are typically considered non-functional at the protein level, but recent research indicates that some pseudogenes may play regulatory roles, for example, by acting as RNA decoys for microRNAs and influencing the expression of related protein-coding genes[5][6]. However, there is no specific scientific evidence linking HAUS4P1 to such functions, nor is it recognized as a therapeutic target, biomarker, or druggable entity. Thus, although it is included in genomic databases, HAUS4P1 is not considered a functional gene or therapeutic target, and its biological and disease roles—if any—remain uncharacterized[4][5][6][3].
not a drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HAUS augmin like complex subunit 4 pseudogene 1 (HAUS4P1).